US drugs giant Pfizer is to pay more than $784 million to settle claims that it overcharged health insurer Medicaid …

Pfizer and Takeda are to split $2.15 billion in damages from two generics manufacturers as a settlement for lost sales, …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

